Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morice, P.
Right arrow Articles by Castaigne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morice, P.
Right arrow Articles by Castaigne, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 18 (September), 2003: 3536-3538
© 2003 American Society for Clinical Oncology


DIAGNOSIS IN ONCOLOGY

Unusual Abdominal and Pelvic Tumors

CASE 2. SPONTANEOUS REGRESSION OF PERITONEAL IMPLANTS IN BORDERLINE OVARIAN TUMOR AFTER SALPINGO-OOPHORECTOMY

P. Morice, A. Thoury, J.C. Sabourin, S. Camatte, D. Atallah, J.P. Armand, P. Madelenat, P. Duvillard, D. Castaigne

Institut Gustave Roussy, Villejuif, France; and Centre Hospitalier Universitaire Bichat, Paris, France

A 49-year-old woman, with a history of right salpingo-oophorectomy for ovarian borderline tumor 20 years previously, underwent a laparoscopic procedure for pelvic pains. A suspicious tumor on the left ovary, with numerous peritoneal implants on the pelvic cavity and a myoma, were found during the laparoscopy. A conversion to laparotomy was performed to carry out a left salpingo-oophorectomy, myomectomy, and peritoneal biopsies. Histologic examinations revealed the presence of serous borderline tumor of the ovary with micropapillary component, positive peritoneal cytology, and noninvasive peritoneal implants (Fig 1Go). At the end of surgical procedure, residual disease was persistent on the peritoneum of the pelvic cavity (numerous peritoneal implants from 1 to 5 mm). A radical surgery (hysterectomy and resection of the peritoneal implants) was proposed, but was refused by the patient. A second-look resection of residual peritoneal implants was planned using a laparoscopic approach 6 months following the salpingo-ooporectomy. At that time, the clinical examination, CA125 antigen level, and abdominopelvic computed tomography scan were normal. During the laparoscopic procedure, we noted an adhesion of the omentum to the uterine scar of myomectomy with 2 peritoneal implants of 2 mm. On the peritoneum of the pelvic cavity an important regression of the peritoneal implants was observed. Several implants of 1 mm were found on the Douglas pouch, on the peritoneum of the broad ligament and on the surface of the peritoneum of the bladder. Large peritonectomies were performed with a partial omentectomy by laparoscopy. There was no residual tumor at the end of this surgical procedure. Histologic examination revealed the presence of only two small, noninvasive implants on the omentum. Calcospherites with fibrosis were found on the surface of the peritoneum, but residual peritoneal implants were absent (Fig 2Go).



View larger version (116K):
[in this window]
[in a new window]
 
Fig 1. Noninvasive implants on the peritoneum removed during initial surgery (hematoxylin and eosin, magnification x50).

 


View larger version (122K):
[in this window]
[in a new window]
 
Fig 2. Aspect of peritoneal lesion removed during second-look surgery. Calcospherites with fibrosis were found on the surface of the peritoneum, but without residual tumoral implants (hematoxylin and eosin, magnification x100).

 
Peritoneal implants from borderline ovarian tumor are defined as invasive or noninvasive depending on the presence or absence of stroma infiltration. The rate of recurrence with invasive disease is 31% in patients with invasive peritoneal implants versus 2% in patients with noninvasive implants.1 Prognosis of patients with noninvasive implants is good. Peritoneal implants are not chemosensitive lesions. The most important therapy is surgery with resection of all macroscopic disease.2 As in patients with ovarian carcinoma, such surgery may involve large resection of the peritoneum with eventually bowel resection in cases of extensive peritoneal implants. Such "debulking" surgery is associated with high morbidity, which could be unacceptable particularly in young patients with noninvasive implants treated conservatively to preserve fertility. Our observation of spontaneous regression of peritoneal implants following resection of the ovarian tumor is exceptional and has important management implications. It could suggest that in young patients with noninvasive implants confirmed by multiple peritoneal biopsies, if the surgery needed to achieve a complete resection of implants would be too aggressive (bowel resection) or unacceptable by the patient, it would be advisable to propose a simple resection of the ovarian tumor with a second look surgery several weeks after this initial operation.

The pathogenesis of peritoneal implants is debated: some authors think that peritoneal implants are "metastases" from the ovarian tumor3 whereas others think that peritoneal and ovarian tumors arise independently in response to the same tumorigenic agents.4 A recent important study using clonality testing (based on inactivation of X chromosome) in patients with ovarian borderline tumor and peritoneal implants suggests that peritoneal implants and the ovarian borderline tumor arise independently.5 Our case suggests that the clinical behavior of peritoneal implants is related to the primary ovarian tumor possibly due to the secretion of prosurvival factors.

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The authors indicated no potential conflicts of interest.

REFERENCES

1. Morice P, Camatte S, Rey A, et al: Prognostic factors of patients with advanced stage serous borderline tumor of the ovary. Ann Oncol 14:592–598, 2003[Abstract/Free Full Text]

2. Gershenson DM: Contemporary treatment of borderline ovarian tumors. Cancer Invest 17:206–210, 1999[Medline]

3. Segal GH, Hart WR: Ovarian serous tumors of low malignant potential (serous borderline tumors): The relationship of exophytic surface tumor to peritoneal "implants." Am J Surg Pathol 16:577–583, 1992[Medline]

4. Russel P: The pathological assessment of ovarian neoplasms, I: Introduction to the common "epithelial" tumours and analysis of benign "epithelial" tumours. Pathology 11:5–26, 1979[Medline]

5. Gu J, Roth LM, Younger C, et al: Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst 93:1147–1152, 2001[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
The OncologistHome page
A. Kane, C. Uzan, A. Rey, S. Gouy, S. Camatte, P. Pautier, C. Lhomme, C. Haie-Meder, P. Duvillard, and P. Morice
Prognostic Factors in Patients with Ovarian Serous Low Malignant Potential (Borderline) Tumors with Peritoneal Implants
Oncologist, June 1, 2009; 14(6): 591 - 600.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morice, P.
Right arrow Articles by Castaigne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morice, P.
Right arrow Articles by Castaigne, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online